Absorption of calcitonin in oral and pulmonary administration with polymer-coated liposomes

Yakugaku Zasshi

Volumn 130, Issue 9, 2010, Pages 1135-1142

  Hirofumi, Takeuchi ^a   Hikaru, Sugihara ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Calcitonin; Oral administration; Polymer coated liposome; Pulmonary administration

Indexed keywords

CALCITONIN; LIPOSOME; NANOPARTICLE; PEPTIDE; POLYMER;

CONFERENCE PAPER; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; GASTROINTESTINAL TRACT; HUMAN; MUCUS; ANIMAL; DRUG DESIGN; INTESTINE ABSORPTION; INTESTINE MUCOSA; LUNG; METABOLISM; MUCOSA; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; CALCITONIN; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LIPOSOMES; LUNG; MUCOUS MEMBRANE; NANOPARTICLES; PEPTIDES; POLYMERS;

EID: 77958536297     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.1135     Document Type: Conference Paper

References (40)

1. Patel H. M., Ryman B. E., FEBS Lett., 62, 60-63 (1976).
2. Dapergolas G., Gregoriadis G., Lancet, 2, 824-827 (1976).
3. Shenfield M., Hill J., Clin. Exp. Pharmacol. Physiol., 9, 355-361 (1982).
4. Damge C., Michel C., Aprahamian M, Couvereur P., Diabetes, 37, 246-251 (1988).
5. Aprahamian M., Michel C., Humbert W., Devissaguet J.-P., Damge C., Biol. Cell, 61, 69-76 (1987).
6. Jani P. U., Halbert G. W., Langridge J., Florence A. T., J. Pharm. Pharmacol., 42, 821-826 (1990).
7. Hillery A. M., Jani P. U., Florence A. T., J. Drug Target., 2, 151-156 (1994).
8. Florence A. T., Pharm. Res., 14, 259-266 (1997).
9. Desai M. P., Labhasetwar V., Amidon G. L., Levy R. J., Pharm. Res., 13, 1838-1845 (1996).
10. Patel H. M., Ryman B. E., Biochem. Soc. Trans., 5, 1739-1741 (1977).
11. Deshmukh D. S., Bear W. D., Brockerhoff H., Life Science, 28, 239-242 (1981).
12. Rowland R. N., Woodley J. F., FEBS Lett., 123, 41-44 (1981).
13. Rowland R. N., Woodley J. F., Biochim. Biophys. Acta, 673, 217-223 (1981).
14. Rowland R. N., Woodley J. F., Biosci. Rep., 1, 345-352 (1981).
15. Whitmore D. A., Wheeler K. P., Biochem. Soc. Trans., 7, 929-931 (1979).
16. Seiden A., Lichtenberg D., J. Pharm. Pharmacol., 31, 414-415 (1979).
17. Schwinke D. L., Ganesan M. G., Weiner N. D., Pharm. Res., 1, 256-259 (1984).
18. Patel H. M., Tuzel N. S., Stevenson R. W., Biochim. Biophys. Acta, 839, 40-49 (1985).
19. Guputa P. K., Leung S-H. S., Robinson J. R., "Bioadhesives/ Mucoadhesives in Drug Delivery to the Gastrointestinal Tract, Bioadhesive Drug Delivery Systems," eds. by Lenaerts V., Gurny R., CRC Press, Boca Raton, 1990, pp. 65-92.
20. Takeuchi H., Kawashima Y., Hyoumen, 32, 423-429 (1994).
21. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y., Chem. Pharm. Bull., 42, 1954-1956 (1994).
22. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y., Pharm. Res., 13, 896-901 (1996).
23. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y., J. Control. Release, 86, 235-242 (2003).
24. Takeuchi H., Thongborisute J., Matsui Y., Sugihara H., Yamamoto H. Kawashima Y., Adv. Drug Deliv. Rev., 57, 1583-1594 (2005).
25. Thongborisute J., Takeuchi H., Int. J. Pharm., 354, 204-209 (2008).
26. Schipper N. G. M., Varum K. M., Artursson P., Pharm. Res., 13, 1686-1692 (1996).
27. Luessen H. L., Leeuw B. J., Langemeyer M. W. E., Boer A. G., Verhoef J. C., Junginger H. E., Pharm. Res., 13, 1668-1672 (1996).
28. Takeuchi H., Yamamoto H., Kawashima Y., Adv. Drug Deliv. Rev., 47, 39-54 (2001).
29. Takeuchi H., Matsui Y., Sugihara H., Yamamoto H., Kawashima Y., Int. J. Pharm., 303, 160-170 (2005).
30. Kawashima Y., Yamamoto H., Takeuchi H., Kuno Y., Pharm. Develop. Technol., 5, 77-85 (2000).
31. Thongborisute J., Takeuchi H., Yamamoto H., Kawashima Y., J. Liposome Res., 16, 127-141 (2006).
32. Thongborisute J., Tsuruta A., Kawabata Y., Takeuchi H., J. Drug Target., 14, 147-154 (2006).
33. Thongborisute J., Takeuchi H., Yamamoto H., Kawashima Y., Die Pharmazie, 61, 106-111 (2006).
34. Thirawong N., Thongborisute J., Takeuchi H., Sriamornsak P., J. Control. Release, 125, 236-245 (2008).
35. Werle M., Takeuchi H., Int. J. Pharm., 370, 26-32 (2009).
36. Werle M., Hironaka K., Takeuchi H., Drug Dev. Ind. Pharm., 35, 209-215 (2009).
37. Werle M., Takeuchi H., Bernkop-Schnürch A., J. Pharm. Sci., 98, 1643-1656 (2009).
38. Yamamoto H., Kuno Y., Sugimoto S., Takeuchi H., Kawashima Y., J. Control. Release, 102, 373-381 (2005).
39. Takeuchi H., Yokoyama R., Tozuka Y., Werle M., Proceedings of the 129th Annual Meeting of the Pharmaceutical Society of Japan, Kyoto, March 2009, No. 1, p. 148.
40. Murata M., Nakano K., Tozuka Y., Toyobuku H., Takeuchi H., Proceedings of the 26th Symposium on Particulate Preparation and Designs, Hiroshima, November 2009, pp. 166-167.